Kastus Technologies: Funding, Investors & Team (Sep 2026)
Kastus’ patented surface technology was initially developed in response to government, industry and healthcare requests to help reduce the spread of antibiotic-resistant infections, specifically those caused by bacteria and fungus surviving on surfaces and indoor environments. After over 10-years of advanced research and development, Kastus was formally founded in 2014 by John Browne, leading the company to where it is today. Kastus today is an Award-Winning surface innovation company with global headquarters and manufacturing based in Ireland. Our patented range of Antiviral and Antibacterial surface coatings are designed to enhance surfaces across our range of products and integrated solutions. Our ISO validated coating technology has been proven to kill >99% of harmful bacteria, common viruses, fungi and antibiotic-resistant superbugs, which makes it particularly useful for products including glass and ceramics. This year, an independent ISO test report found Kastus is also proven to kill >99% of human coronavirus. In 2020, Kastus have actively helped businesses to reopen safely from lockdown with the launch of our New Antiviral and Antimicrobial screen protectors. A unique, easy to install product, designed to help businesses better protect their touchscreens. Following the launch of our screen protectors we have recently been awarded EU Funding for developing an innovative business solution to help fight Covid-19.
Kastus Technologies has raised $6.7M across 1 funding round on record, the most recent an undisclosed round of $6.7M announced in Jun 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kastus Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Kastus Technologies Funding Rounds
Kastus Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Kastus Technologies Funding Compared to Other Biotechnology Startups
Kastus Technologies' latest round of $6.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kastus Technologies in Biotechnology and Dublin
Companies Similar to Kastus Technologies
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed…
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target…
Kastus Technologies Funding FAQs
What does Kastus Technologies do?
Kastus’ patented surface technology was initially developed in response to government, industry and healthcare requests to help reduce the spread of antibiotic-resistant infections, specifically those caused by bacteria and fungus surviving on surfaces and indoor environments. After over 10-years of advanced research and development, Kastus was formally founded in 2014 by John Browne, leading the company to where it is today. Kastus today is an Award-Winning surface innovation company with global headquarters and manufacturing based in Ireland. Our patented range of Antiviral and Antibacterial surface coatings are designed to enhance surfaces across our range of products and integrated solutions. Our ISO validated coating technology has been proven to kill >99% of harmful bacteria, common viruses, fungi and antibiotic-resistant superbugs, which makes it particularly useful for products including glass and ceramics. This year, an independent ISO test report found Kastus is also proven to kill >99% of human coronavirus. In 2020, Kastus have actively helped businesses to reopen safely from lockdown with the launch of our New Antiviral and Antimicrobial screen protectors. A unique, easy to install product, designed to help businesses better protect their touchscreens. Following the launch of our screen protectors we have recently been awarded EU Funding for developing an innovative business solution to help fight Covid-19.
How much funding has Kastus Technologies raised?
Kastus Technologies has raised $6.7M across 1 round on record. The most recent is an undisclosed round of $6.7M announced in Jun 2021.
When did Kastus Technologies last raise funding?
Kastus Technologies' most recent funding round on record is an undisclosed round of $6.7M, announced in Jun 2021.
Who is the CEO of Kastus Technologies?
John Browne is listed as CEO at Kastus Technologies.
Where is Kastus Technologies headquartered?
Kastus Technologies is based in Dublin, Ireland.
How many employees does Kastus Technologies have?
Kastus Technologies is in the 11-50 employee band.
How does Kastus Technologies' funding compare to other Biotechnology startups?
Kastus Technologies' latest round of $6.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kastus Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kastus Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.